Akebia Therapeutics, Inc.

Q2 2017 13F Holders

Symbol
AKBA
CUSIP
00972D105
Type
Equity
Class
COM
Num filers
119
Total reported value, excl. options
$392M
Manager Report Date Value ($000) Shares